|
Session 109
Poster Abstracts
Diagnostics: Co-Receptor Expression and Categorization
Wednesday, 1:30 - 3:30 pm
Poster Hall |
| 655 |
Co-receptor Tropism in Patients Screening for ACTG 5211, a Phase 2 Study of Vicriviroc, a CCR5 Inhibitor
Timothy Wilkin*1, Z Su2, D Kuritzkes3, M Hughes2, C Flexner4, R Gross5, E Coakley6, W Greaves7, C Godfrey8, and R Gulick1
1Weill-Cornell Med Coll, New York, NY, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Brigham and Women's Hosp, Boston, MA, US; 4Johns Hopkins Univ, Baltimore, MD, US; 5Univ of Pennsylvania, Philadelphia, US; 6Monogram Biosci, South San Francisco, CA, US; 7Schering-Plough Res Inst, Kenilworth, NJ, US; and 8NIAID, NIH, DHHS, Bethesda, MD, US |
| 656 |
Comparison of Two Co-receptor Prediction Algorithms
Ina Vandenbroucke*, V Van Eygen, A Deloof, K Van Der Borght, H Vermeiren, and L Stuyver
Virco BVBA, Mechelen, Belgium |
| 657 |
Measuring HIV Coreceptor Tropism and SI Phenotype in Archived Samples: A Comparison of Different Methods
Nancy Shulman*, E Johnston, M Winters, and D Katzenstein
Stanford Univ Sch of Med, Palo Alto, CA, US |
| 658 |
Is there a Gold Standard for Determining HIV Co-receptor usage in Clinical Samples? A Comparison of Two Phenotypic Assays and a Bioinformatic Model
Andrew Low*1, K Skrabal2, W Dong1, F Mammano2, T Sing3, P Cheung1, and R Harrigan1
1BC Ctr for Excellence in HIV/AIDS, St Paul's Hosp, Vancouver, Canada; 2INSERM U552, Paris, France; and 3Max-Planck-Inst for Informatics, Saarbrucken, Germany |
|
